Chest Physiotherapy in Pediatrics Patients With Pneumonia

This study has been completed.
Sponsor:
Collaborator:
Federal University of Rio Grande do Sul
Information provided by:
Santa Casa de Porto Alegre
ClinicalTrials.gov Identifier:
NCT01017081
First received: November 19, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
  Purpose

Chest physiotherapy has been used to treat pediatric patients hospitalized with pneumonia however there was no evidence to support a beneficial effect in pediatric patients.


Condition Intervention
Pneumonia
Other: Physiotherapy
Other: Positioning and cough

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Chest Physiotherapy in Pediatric Patients Hospitalised With Community-acquired Pneumonia: a Randomized Clinical Trial

Resource links provided by NLM:


Further study details as provided by Santa Casa de Porto Alegre:

Enrollment: 72
Study Start Date: September 2001
Study Completion Date: September 2002
Primary Completion Date: September 2002 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Control
Non-mandatory request to maintain lateral positioning to improve air exchange, to cough in order to clear secretion, and to perform diaphragmatic and deep breathing, for five minutes, once a day, during hospital stay.
Other: Positioning and cough
Non-mandatory request to maintain lateral positioning to improve air exchange and cough
Experimental: Physiotherapy
Physiotherapy: Children younger than 5 years: Manual Thoracic vibration (TV), thoracic compression (TC), positive expiratory pressure (PEP), and forced exhalation with the glottis open ("huffing"). Children aged 5 years or older: same procedures in addition to the ventilatory patterns, and a forced expiratory technique (FET), consisting of one or two "huffs" (forced expirations) followed by a period of relaxed, controlled diaphragmatic breathing, three times per day, for 10 to 12 minutes, during hospital admission.
Other: Physiotherapy
Physiotherapy: three times per day, for 10 to 12 minutes, during hospital admission

  Eligibility

Ages Eligible for Study:   1 Year to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children aged 1 to 12 years with acute community-acquired pneumonia (cough, tachypnea, fever and with a chest radiography with lobar, segmental or bronchopneumonia within the first 48 hours)

Exclusion Criteria:

  • Severely ill patients (hospitalized in intensive care units)
  • Pleural effusion treated with chest drainage
  • Atelectasis detected by x-ray
  • Pneumonia or pleural effusion in the previous six months
  • Other pulmonary underlying disease, heart disease, cerebral palsy or immune deficiency
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01017081

Locations
Brazil
Santa Casa de Porto Alegre
Posto Alegre, Rio Grande do Sul, Brazil, 90020-160
Sponsors and Collaborators
Santa Casa de Porto Alegre
Federal University of Rio Grande do Sul
  More Information

No publications provided

Responsible Party: Universidade Federal do Rio Grande do Sul, Janice Luisa Lukrafka
ClinicalTrials.gov Identifier: NCT01017081     History of Changes
Other Study ID Numbers: FISIOPUL
Study First Received: November 19, 2009
Last Updated: November 19, 2009
Health Authority: Brazil: Ethics Committee

Keywords provided by Santa Casa de Porto Alegre:
physiotherapy
children
clinical trial

Additional relevant MeSH terms:
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections

ClinicalTrials.gov processed this record on September 18, 2014